Case-based clinical approach demonstrates effective management of suspected meningococcal disease in a young male, underscoring adherence to guidelines and NMP roles.
Key Points
To evaluate the assessment, diagnosis, and management of suspected invasive meningococcal disease (IMD) in a clinical case.
Structured assessment based on the Calgary-Cambridge model including clinical findings and laboratory investigations.
Treatment with intravenous ceftriaxone 2 g every 12 hours and oral ibuprofen 400 mg every 8 hours.
Patient history included symptoms such as fever, purpuric rash, photophobia, and headache.
Diagnosis of serogroup C IMD confirmed in hospital, leading to prompt treatment.
Patient recovered fully within 10 days without adverse effects.
Highlights effective use of third-generation cephalosporins for improving clinical outcomes.